Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Cash from Financing Activities (2010 - 2026)

Omnicell's (OMCL) quarterly Cash from Financing Activities came in at -$23.4 million in Q2 2026, down 103.81% year-over-year from $613.5 million in Q2 2025, and down 1077.62% quarter-over-quarter from $2.4 million in Q1 2026.

Analysis

Omnicell (OMCL) Cash from Financing Activities (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Cash from Financing Activities for 17 consecutive years, with -$23.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities fell 103.81% year-over-year to -$23.4 million in Q2 2026; TTM through Jun 2026 was -$231.9 million, a 2.7% increase from a year earlier, with the FY2025 full-year figure at -$218.3 million, up 7.33% from the prior year.
  • Cash from Financing Activities was -$23.4 million for Q2 2026 at Omnicell, down from $2.4 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $13.1 million in Q4 2023 and troughed at -$234.4 million in Q4 2024.
  • A 5-year average of -$26.2 million and a median of $3.2 million in 2023 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities surged 348.14% in 2023 and tumbled 6289.67% in 2025, its largest moves.
  • Over 5 years, Cash from Financing Activities stood at $3.6 million in 2022, then jumped by 268.61% to $13.1 million in 2023, then sank by 1885.45% to -$234.4 million in 2024, then soared by 103.88% to $9.1 million in 2025, then sank by 357.01% to -$23.4 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$23.4 million (Q2 2026), $2.4 million (Q1 2026), and $9.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -287.90 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -343.00 Mn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -300,000.00
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -510.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn -607.30 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn -263.16 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn -23.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.38 Mn
Mar 31, 2026 2.39 Mn
Dec 31, 2025 9.10 Mn
Sep 30, 2025 -219.98 Mn
Jun 30, 2025 -11.47 Mn
Mar 31, 2025 4.04 Mn
Dec 31, 2024 -234.43 Mn
Sep 30, 2024 3.55 Mn
Jun 30, 2024 -16.63 Mn
Mar 31, 2024 11.93 Mn
Dec 31, 2023 13.13 Mn
Sep 30, 2023 2.83 Mn
Jun 30, 2023 3.60 Mn
Mar 31, 2023 3.86 Mn
Dec 31, 2022 3.56 Mn
Sep 30, 2022 9.06 Mn
Jun 30, 2022 -1.45 Mn
Mar 31, 2022 -32.12 Mn
Dec 31, 2021 6.67 Mn
Sep 30, 2021 18.28 Mn